1.9791
price up icon5.27%   0.0991
after-market 시간 외 거래: 1.98 0.0009 +0.05%
loading
전일 마감가:
$1.88
열려 있는:
$1.8834
하루 거래량:
4,616
Relative Volume:
0.26
시가총액:
$182.44M
수익:
$47.04M
순이익/손실:
$-63.98M
주가수익비율:
-2.4542
EPS:
-0.8064
순현금흐름:
$-34.39M
1주 성능:
+9.95%
1개월 성능:
+9.95%
6개월 성능:
+18.51%
1년 성능:
-10.85%
1일 변동 폭
Value
$1.8834
$1.9791
1주일 범위
Value
$1.7509
$1.98
52주 변동 폭
Value
$1.29
$3.5107

Innate Pharma Adr Stock (IPHA) Company Profile

Name
명칭
Innate Pharma Adr
Name
전화
-
Name
주소
-
Name
직원
181
Name
트위터
@InnatePharma
Name
다음 수익 날짜
2024-09-12
Name
최신 SEC 제출 서류
Name
IPHA's Discussions on Twitter

IPHA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IPHA
Innate Pharma Adr
1.9791 173.27M 47.04M -63.98M -34.39M -0.8064
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Innate Pharma Adr Stock (IPHA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-09-03 업그레이드 SVB Leerink Mkt Perform → Outperform
2020-12-15 다운그레이드 SVB Leerink Outperform → Mkt Perform
2020-11-24 개시 Goldman Neutral

Innate Pharma Adr 주식(IPHA)의 최신 뉴스

pulisher
Jul 21, 2025

Cutaneous T-cell Lymphoma Market Anticipates Impressive Growth Trajectory at a CAGR of 7.1% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 17, 2025

Innate Pharma (NASDAQ:IPHA) Trading 1.7% Higher – What’s Next? - Defense World

Jul 17, 2025
pulisher
Jun 25, 2025

Exchange Traded Concepts LLC Has $112,000 Stock Position in Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) - Defense World

Jun 25, 2025
pulisher
May 28, 2025

Why Kingsoft Cloud Holdings Stock Plummeted by Nearly 8% Today - The Globe and Mail

May 28, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook - Investing.com

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
Apr 30, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 29, 2025

Innate Pharma stock surges on promising preclinical data By Investing.com - Investing.com South Africa

Apr 29, 2025
pulisher
Apr 29, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 - Investing.com

Apr 29, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock - Investing.com

Apr 24, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Innate Pharma Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances - Investing.com

Mar 27, 2025
pulisher
Jan 17, 2025

Innate Pharma shares retain Buy rating on long-term strategy - Investing.com

Jan 17, 2025
pulisher
Dec 23, 2024

AZN Stock Price and Chart — LSE:AZN - TradingView

Dec 23, 2024
pulisher
Aug 06, 2024

Contrast Security Introduces Application Detection and Response (ADR) to Identify and Block Attacks and Zero Days on Applications in Production - Business Wire

Aug 06, 2024
pulisher
Jun 10, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Jun 10, 2024
pulisher
Mar 31, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 31, 2024
pulisher
Jan 04, 2024

Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study - Nasdaq

Jan 04, 2024
pulisher
Apr 29, 2022

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities.com

Apr 29, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Nov 01, 2019

Innate Pharma (IPHA) Stock Price, News & Analysis - MarketBeat

Nov 01, 2019

Innate Pharma Adr (IPHA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):